UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 118

Sortiert nach

Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016-Present)

Molecules (Basel, Switzerland), 2020-06, Vol.25 (11), p.2666

2020

Link zum Volltext

Verfügbarkeit prüfen

Indole-Based Tubulin Inhibitors: Binding Modes and SARs Investigations

Molecules (Basel, Switzerland), 2022-02, Vol.27 (5), p.1587

2022

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present)

Expert opinion on therapeutic patents, 2021-03, Vol.31 (3), p.223-238

2021

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Different cell death modes in cancer treatment

Frontiers in pharmacology, 2023-09, Vol.14, p.1291585-1291585

2023

Link zum Volltext

Verfügbarkeit prüfen

A Novel Dual PI3K/mTOR Inhibitor, XIN-10, for the Treatment of Cancer

International journal of molecular sciences, 2023-10, Vol.24 (19), p.14821

2023

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, and Antitumor Activity of Olmutinib Derivatives Containing Acrylamide Moiety

Molecules (Basel, Switzerland), 2021-05, Vol.26 (10), p.3041

2021

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit

Molecules (Basel, Switzerland), 2015-10, Vol.20 (10), p.19361-19371

2015

Link zum Volltext

Verfügbarkeit prüfen

A Hemin-Graphene Nanocomposite-Based Aptasensor for Ultrasensitive Colorimetric Quantification of Leukaemia Cells Using Magnetic Enrichment

Biosensors (Basel), 2022-11, Vol.12 (12), p.1070

2022

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis and Biological Evaluation of 6,7-Disubstituted-4-phenoxyquinoline Derivatives Bearing Pyridazinone Moiety as c-Met Inhibitors

Molecules (Basel, Switzerland), 2018-06, Vol.23 (7), p.1543

2018

Link zum Volltext

Verfügbarkeit prüfen

XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer

Biomedicine & pharmacotherapy, 2022-11, Vol.155, p.113537-113537, Article 113537

2022

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Structure-Activity Relationships of 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]pyrimidine Derivatives Bearing Pyrazoline Scaffold

Molecules (Basel, Switzerland), 2017-10, Vol.22 (11), p.1870

2017

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, and Biological Evaluation of Novel Thienopyrimidine Derivatives as PI3Kα Inhibitors

Molecules (Basel, Switzerland), 2019-09, Vol.24 (19), p.3422

2019

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors

Molecules (Basel, Switzerland), 2018-06, Vol.23 (7), p.1553

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitors

Translational oncology, 2024-01, Vol.39, p.101834-101834, Article 101834

2024

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Biological Evaluation of Novel 8-Morpholinoimidazo[1,2-a]pyrazine Derivatives Bearing Phenylpyridine/Phenylpyrimidine-Carboxamides

Molecules (Basel, Switzerland), 2017-02, Vol.22 (2), p.310-310

2017

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis and Anticancer Activity of 4-Morpholinothieno[3,2-d]pyrimidine Derivatives Bearing Arylmethylene Hydrazine Moiety

Chemical and Pharmaceutical Bulletin, 2012/08/01, Vol.60(8), pp.1037-1045

2012

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3- a ] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors

Frontiers in chemistry, 2022-04, Vol.10, p.815534-815534

2022

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers

Journal of enzyme inhibition and medicinal chemistry, 2019-01, Vol.34 (1), p.203-217

2019

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Biological Evaluation of Novel 4-Morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine Derivatives Bearing Phenylpyridine/ Phenylpyrimidine-Carboxamides

Molecules (Basel, Switzerland), 2016-10, Vol.21 (11), p.1447-1447

2016

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis and 3D-QSAR analysis of novel 2-hydrazinyl-4-morpholinothieno[3,2-d]pyrimidine derivatives as potential antitumor agents

European journal of medicinal chemistry, 2012-11, Vol.57, p.162-175

2012

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis and Antitumor Activity of Novel Artemisinin Derivatives Using Hybrid Approach

Chemical and Pharmaceutical Bulletin, 2011/08/01, Vol.59(8), pp.984-990

2011

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Anticancer Activity of Indolin-2-one Derivatives Bearing the 4-Thiazolidinone Moiety

Archiv der Pharmazie (Weinheim), 2012-01, Vol.345 (1), p.73-80

2012

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Triazolo-pyridazine/-pyrimidine Derivatives Bearing Aromatic (Heterocycle)-Coupled Azole Units as Class II c‑Met Inhibitors

ACS omega, 2020-07, Vol.5 (27), p.16482-16490

2020

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, Biological Evaluation and Docking Studies of Sorafenib Derivatives N-(3-fluoro-4-(pyridin-4-yloxy)phenyl)-4(5)-phenylpicolinamides

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2017-03, Vol.13 (2), p.176

2017

Link zum Volltext

Verfügbarkeit prüfen

Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors

Computational and structural biotechnology journal, 2018-01, Vol.16, p.462-478

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(117)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016-Present)

Indole-Based Tubulin Inhibitors: Binding Modes and SARs Investigations

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present)

Editorial: Different cell death modes in cancer treatment

A Novel Dual PI3K/mTOR Inhibitor, XIN-10, for the Treatment of Cancer

Design, Synthesis, and Antitumor Activity of Olmutinib Derivatives Containing Acrylamide Moiety

Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit

A Hemin-Graphene Nanocomposite-Based Aptasensor for Ultrasensitive Colorimetric Quantification of Leukaemia Cells Using Magnetic Enrichment

Design, Synthesis and Biological Evaluation of 6,7-Disubstituted-4-phenoxyquinoline Derivatives Bearing Pyridazinone Moiety as c-Met Inhibitors

XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer

Synthesis and Structure-Activity Relationships of 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]pyrimidine Derivatives Bearing Pyrazoline Scaffold

Design, Synthesis, and Biological Evaluation of Novel Thienopyrimidine Derivatives as PI3Kα Inhibitors

Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors

Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitors

Synthesis and Biological Evaluation of Novel 8-Morpholinoimidazo[1,2-a]pyrazine Derivatives Bearing Phenylpyridine/Phenylpyrimidine-Carboxamides

Design, Synthesis and Anticancer Activity of 4-Morpholinothieno[3,2-d]pyrimidine Derivatives Bearing Arylmethylene Hydrazine Moiety

Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3- a ] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors

Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers

Synthesis and Biological Evaluation of Novel 4-Morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine Derivatives Bearing Phenylpyridine/ Phenylpyrimidine-Carboxamides

Design, synthesis and 3D-QSAR analysis of novel 2-hydrazinyl-4-morpholinothieno[3,2-d]pyrimidine derivatives as potential antitumor agents

Design, Synthesis and Antitumor Activity of Novel Artemisinin Derivatives Using Hybrid Approach

Synthesis and Anticancer Activity of Indolin-2-one Derivatives Bearing the 4-Thiazolidinone Moiety

Discovery of Triazolo-pyridazine/-pyrimidine Derivatives Bearing Aromatic (Heterocycle)-Coupled Azole Units as Class II c‑Met Inhibitors

Synthesis, Biological Evaluation and Docking Studies of Sorafenib Derivatives N-(3-fluoro-4-(pyridin-4-yloxy)phenyl)-4(5)-phenylpicolinamides

Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors

Suchergebnisse filtern